|
RNF2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.077000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.684800E-01 |
| Normal-vs-Stage2 |
7.623800E-01 |
| Normal-vs-Stage3 |
7.423400E-01 |
| Normal-vs-Stage4 |
1.901610E-01 |
| Stage1-vs-Stage2 |
8.600800E-01 |
| Stage1-vs-Stage3 |
2.209000E-01 |
| Stage1-vs-Stage4 |
2.578200E-02 |
| Stage2-vs-Stage3 |
5.794600E-01 |
| Stage2-vs-Stage4 |
2.330200E-01 |
| Stage3-vs-Stage4 |
3.520400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.095800E-01 |
| Normal-vs-AfricanAmerican |
4.461900E-02 |
| Normal-vs-Asian |
1.687230E-01 |
| Caucasian-vs-AfricanAmerican |
6.677800E-03 |
| Caucasian-vs-Asian |
3.121000E-01 |
| AfricanAmerican-vs-Asian |
2.540200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.230600E-01 |
| Normal-vs-Female |
6.493000E-01 |
| Male-vs-Female |
4.868800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.311400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.007800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.728200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.733800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.105400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.644800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.709200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.905200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.413200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.812550E-01 |
| Normal-vs-Grade 2 |
1.167370E-01 |
| Normal-vs-Grade 3 |
3.819000E-01 |
| Normal-vs-Grade 4 |
9.637900E-02 |
| Grade 1-vs-Grade 2 |
6.754000E-01 |
| Grade 1-vs-Grade 3 |
6.970400E-02 |
| Grade 1-vs-Grade 4 |
3.948400E-02 |
| Grade 2-vs-Grade 3 |
2.642800E-03 |
| Grade 2-vs-Grade 4 |
1.204860E-03 |
| Grade 3-vs-Grade 4 |
2.295400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.666100E-02 |
| Normal-vs-ccB subtype |
7.556600E-01 |
| ccA subtype-vs-ccB subtype |
6.340200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.996600E-01 |
| Normal-vs-N1 |
9.229400E-01 |
| N0-vs-N1 |
7.952400E-01 |
|
|
